about us… locationdosage formapprovals goa i tablets, creams & ointments us-fda eu-gmp tga...

Post on 16-Dec-2015

223 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

About Us…

About Us…

LOCATION DOSAGE FORM APPROVALS

GOA I TABLETS, CREAMS & OINTMENTS

US-FDA EU-GMP TGA Australia MCC South Africa ANVISA – Brazil

GOA II STERILE PRODUCTS Same as above

GOA III TABLETS US-FDA EU-GMP TGA Australia

WALUJ TABLETS Emerging Markets

BADDI TABLETS, LIQUID

ORALS & TOOTHPASTES

EU–GMP and Emerging Markets

PATALGANGA APIs US-FDA, TGA Australia

KILOLAB APIs US-FDA, TGA Australia

Regulatory Approvals

• Branded Generics

• Active Pharmaceutical Ingredients (APIs) (Captive Consumption & Supply to end users)

INDIAN BUSINESS

• Regulated Markets - Generics - CRAMS

• Emerging Markets - Branded Generics

INTERNATIONAL BUSINESS

(Covers 80 countries)

• AnaCipher (Analytical Services)• Xtend Industrial Designers and Engineers

ALLIED SERVICES

Business Model

ANTI-INFECT16%

CARDIAC12%

GASTRO INTEST11%

VIT / MIN/ NUT9%

RESPIRAT8%

PAIN / ANALG7%

ANTI DIABETIC7%

NEURO / CNS6%

DERMA6%

GYNAEC 5%

OTHERS12%

Indian Pharma Market (IPM)

RESPIRAT20%

ANTI-INFECT17%

STOMATO16%

GASTRO INTEST14%

OPHTHAL 5%

UROLOGY4%

PAIN / ANALG5%

VIT / MIN/ NUTR5%

DERMA4%

ANTI DIAB / CARDIAC

6%

OTHERS4%

Indoco Remedies

Top Therapy Contributors 2013-2014

Indian Formulation Business

Market Size Rs. 76,640 Crs

Source : AWACs

Marketing Divisions Doctor’s Specialties Covered

INDOCO Multi Specialty Division with focus on Consulting Physicians

SPADE Multi Specialty Division with focus on Consulting Physicians

WARREN Dentists

EXCEL Ophthalmologists

SPERA Gynecologists, General Practitioners

ETERNA Orthopedicians

INDOCO CND Cardiologists, Diabetologists, Consulting Physicians

HOSPITAL / INSTITUTION Hospitals (Private & Government )

TOP BRANDS

FEBREX PLUS

CYCLOPAM

SENSODENT K

ATM

OXIPOD

SENSOFORM

CLOBEN G

CITAL

SENSODENT KF

KARVOL PLUSIndoco generates 50 Million Prescriptions Annually (Source : CMARC)

Indian Formulation Business

• Increasing income levels, rapid urbanization, demand for quality healthcare services and changing lifestyle

• Brand building and focus on chronic segment

• Penetration in Northern and Eastern Regions to achieve regional balance

• New Products introductions• (Around 20 products including brand extensions every year)

• Focus on developing sustainable Rx support from core prescribers of Indoco brands

• Significant API contribution with expanded product basket and services

Indian Business - Growth Drivers

Revenue of

Rs. 200 Crs in 2013-14

Revenue contribution

(Europe 51%, USA 22 %,

SA & ANZ 13%) CRAMS, FDF, APIs

MAs / Dossier

Out-Licensing

Regulated Markets

(87% of

Exports)

Revenue of

Rs. 31 Crs in 2013-14

Revenue Contribution

(Africa 8%, Asia 2%,

Latam 2% )

Promotion of Branded

Generics through

Distributors

Emerging Markets

(13% of

Exports)

International Business

Partnership and alliances to provide impetus to international business

Regulatory approvals from countries including US / Europe for manufacturing facilities and products

Own filing of ANDAs and Dossiers

Shift from CRAMS to supplies against own dossiers / marketing authorizations in regulated markets

Creation of own Intellectual Property through Patents and Trademarks

NDDS and new platform technologies for future commercial exploitation

International Business - Growth Drivers

68%

27%

5%

2008-09

61%

32%

6%

2013-14

91%

7% 2%

2003-04

Segment wise Break-up and Contribution

Highlights – Third Quarter & Nine Months Results FY15

(Rs. In Crs)

ParticularsThird Quarter Nine Months

TY PY Gwth% TY PYGwth

%

Net Revenue 213 188 13.0 637 532 19.9

EBITDA 43 30 43.0 128 87 46.7

% to Sales 20.1 15.8   20.1 16.4  

PBT 28 18 56.0 87 50 74.8

% to Sales 13.2 9.6   13.6 9.3  

PAT 22 14 53.1 64 39 62.8

% to Sales 10.1 7.5   10.1 7.4  

Diluted EPS (Rs)

2.35 1.53 6.95 4.27

604Dec'12

1263Dec'13

2710Dec'14

Increase in Shareholder’s Wealth

59%

11%

8%

22%

Shareholding Pattern

Promoters Mutual Funds Foreign Institutions

Public /Others

Share Holding Pattern and MCAP

(Rs. Crs)

• Strategies – - Run healthy core businesses - Leverage strengths into new products and services - Open new frontiers, viz., CRO, Allied Services

• Core Competencies – - Detailed customer knowledge and focus - Large scale systems integration - Lean enterprise - To embark upon proactive measures (e.g. GST, SAP, IFRS,etc)

• Values – - Integrity - Quality - Customer satisfaction - Team spirit - Good corporate citizenship - Leadership

Roadmap for Growth

Thank You

Many Minds, Many Hands, One Goal

top related